adult; antiviral therapy; article; catalysis; clinical research; controlled study; coronavirus disease 2019; covalent bond; drug bioavailability; drug combination; drug safety; drug therapy; enzyme activity; hospitalization; human; molecular interaction; mortality; nonhuman; oral drug administration; pandemic; patent; pill; scale up; Severe acute respiratory syndrome coronavirus 2; synthesis; antivirus agent; endogenous compound; nirmatrelvir; ritonavir; viral protease